Standard

Adaptation of the newcastle disease virus to cell cultures for enhancing its oncolytic properties. / Yurchenko, K. S.; Jing, Yi; Shestopalov, A. M.

в: Acta Naturae, Том 11, № 1, 01.01.2019, стр. 66-73.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Yurchenko, KS, Jing, Y & Shestopalov, AM 2019, 'Adaptation of the newcastle disease virus to cell cultures for enhancing its oncolytic properties', Acta Naturae, Том. 11, № 1, стр. 66-73. https://doi.org/10.32607/20758251-2019-11-1-66-73

APA

Vancouver

Yurchenko KS, Jing Y, Shestopalov AM. Adaptation of the newcastle disease virus to cell cultures for enhancing its oncolytic properties. Acta Naturae. 2019 янв. 1;11(1):66-73. doi: 10.32607/20758251-2019-11-1-66-73

Author

Yurchenko, K. S. ; Jing, Yi ; Shestopalov, A. M. / Adaptation of the newcastle disease virus to cell cultures for enhancing its oncolytic properties. в: Acta Naturae. 2019 ; Том 11, № 1. стр. 66-73.

BibTeX

@article{df72e12d024e44cfaeeba622d8ade0ab,
title = "Adaptation of the newcastle disease virus to cell cultures for enhancing its oncolytic properties",
abstract = "This study focuses on the adaptation of natural Newcastle disease virus (NDV) strains isolated from wild birds to human tumor cells. Many candidates for virotherapy are viruses pathogenic for human. During recombination of genetic material, there always exists a risk of getting a virus with an unstable genome. This problem can be solved by using natural apathogenic viruses as oncolytic agents. The Newcastle disease virus is the causative agent of contagious avian diseases. Its natural strains exhibit an antitumor effect and are considered safe for humans. As shown in earlier studies, the oncolytic properties of natural strains can be enhanced during adaptation to cell cultures, without interference in the virus genome. This study demonstrates that serial passaging increases the viral infectious titer in cancer cells. Moreover, the viability of tumor cells decreases post-infection when Newcastle disease virus strains are adapted to these cell cultures. The findings of this study complement the well-known data on the adaptation of the Newcastle disease virus to human cancer cells. Hence, it is possible to obtain a NDV strain with a more pronounced oncolytic potential during adaptation. This should be taken into account when choosing a strategy for designing anticancer drugs based on this virus.",
keywords = "Adaptation, Cytotoxic effect, Newcastle disease virus, Oncolytic properties, Tumor cells",
author = "Yurchenko, {K. S.} and Yi Jing and Shestopalov, {A. M.}",
year = "2019",
month = jan,
day = "1",
doi = "10.32607/20758251-2019-11-1-66-73",
language = "English",
volume = "11",
pages = "66--73",
journal = "Acta Naturae",
issn = "2075-8251",
publisher = "Park Media Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Adaptation of the newcastle disease virus to cell cultures for enhancing its oncolytic properties

AU - Yurchenko, K. S.

AU - Jing, Yi

AU - Shestopalov, A. M.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This study focuses on the adaptation of natural Newcastle disease virus (NDV) strains isolated from wild birds to human tumor cells. Many candidates for virotherapy are viruses pathogenic for human. During recombination of genetic material, there always exists a risk of getting a virus with an unstable genome. This problem can be solved by using natural apathogenic viruses as oncolytic agents. The Newcastle disease virus is the causative agent of contagious avian diseases. Its natural strains exhibit an antitumor effect and are considered safe for humans. As shown in earlier studies, the oncolytic properties of natural strains can be enhanced during adaptation to cell cultures, without interference in the virus genome. This study demonstrates that serial passaging increases the viral infectious titer in cancer cells. Moreover, the viability of tumor cells decreases post-infection when Newcastle disease virus strains are adapted to these cell cultures. The findings of this study complement the well-known data on the adaptation of the Newcastle disease virus to human cancer cells. Hence, it is possible to obtain a NDV strain with a more pronounced oncolytic potential during adaptation. This should be taken into account when choosing a strategy for designing anticancer drugs based on this virus.

AB - This study focuses on the adaptation of natural Newcastle disease virus (NDV) strains isolated from wild birds to human tumor cells. Many candidates for virotherapy are viruses pathogenic for human. During recombination of genetic material, there always exists a risk of getting a virus with an unstable genome. This problem can be solved by using natural apathogenic viruses as oncolytic agents. The Newcastle disease virus is the causative agent of contagious avian diseases. Its natural strains exhibit an antitumor effect and are considered safe for humans. As shown in earlier studies, the oncolytic properties of natural strains can be enhanced during adaptation to cell cultures, without interference in the virus genome. This study demonstrates that serial passaging increases the viral infectious titer in cancer cells. Moreover, the viability of tumor cells decreases post-infection when Newcastle disease virus strains are adapted to these cell cultures. The findings of this study complement the well-known data on the adaptation of the Newcastle disease virus to human cancer cells. Hence, it is possible to obtain a NDV strain with a more pronounced oncolytic potential during adaptation. This should be taken into account when choosing a strategy for designing anticancer drugs based on this virus.

KW - Adaptation

KW - Cytotoxic effect

KW - Newcastle disease virus

KW - Oncolytic properties

KW - Tumor cells

UR - http://www.scopus.com/inward/record.url?scp=85065537039&partnerID=8YFLogxK

U2 - 10.32607/20758251-2019-11-1-66-73

DO - 10.32607/20758251-2019-11-1-66-73

M3 - Article

AN - SCOPUS:85065537039

VL - 11

SP - 66

EP - 73

JO - Acta Naturae

JF - Acta Naturae

SN - 2075-8251

IS - 1

ER -

ID: 20181580